CBD 101:
Where Is CBD Legal in the United States? Cannabis, Hemp, and CBD Laws (2026)
Add MyCannabis.com to your preferred sources on Google
CBD is not subject to one nationwide retail rule. A product can qualify as hemp under federal controlled-substance law while still violating food, supplement, labeling, or state requirements. The answer depends on its source, composition, intended use, and where it is manufactured, sold, or carried.
There are also two upcoming federal deadlines. Legislation signed in September 2026 delays most of the new hemp restrictions until December 11, 2026, while specified exclusions retain a November 12 start. Neither deadline suspends existing state or FDA requirements.
Is Hemp-Derived CBD Federally Legal?
The 2018 Farm Bill removed qualifying hemp from the Controlled Substances Act’s definition of marijuana. Its definition uses no more than 0.3% delta-9 THC on a dry-weight basis and includes qualifying derivatives and extracts. The DEA explains that compliant hemp and CBD preparations are not controlled as marijuana.
That exemption does not approve every CBD product for sale. An oil, gummy, beverage, cream, or medicine must also satisfy the requirements applicable to that product category. A hemp supplier’s certificate cannot replace a food authorization, a required state registration, or approval of a medicine.
Nor does a low delta-9 result alone settle every hemp question. Federal cultivation compliance involves testing that accounts for conversion of THCA to THC. State retail rules can also use total THC or impose additional limits. The distinction between a production test and a finished-product rule matters.
The November and December 2026 Hemp Deadlines
Section 781 of Public Law 119-37 rewrites the federal hemp definition. Its original effective date was November 12, 2026. The President signed H.R. 6500 on September 2, 2026, and its Section 2019 extends the timetable for most amendments to December 11.
| Effective date | Federal change |
|---|---|
| November 12, 2026 | Intermediate and final hemp-derived cannabinoid products containing cannabinoids that the cannabis plant cannot naturally produce are excluded from hemp. |
| December 11, 2026 | Most remaining amendments apply, including the revised total-THC definition, exclusions for naturally producible cannabinoids synthesized or manufactured outside the plant, and the finished-product container limit. |
The revised definition counts total tetrahydrocannabinols, including THCA, toward the 0.3% dry-weight threshold. Finished hemp-derived cannabinoid products are excluded if they contain more than 0.4 milligrams per container of combined total THC, including THCA, and other cannabinoids with similar effects or marketed similar effects, as determined by the Health and Human Services Secretary. This is not 0.4 mg of CBD, and it is not a per-serving allowance.
Consequently, a full-spectrum CBD bottle can be affected even if each serving is not marketed as intoxicating. Whether a particular product remains hemp depends on the complete formulation and applicable definitions. The November exclusions are narrower than a blanket description of “all synthetic cannabinoids”; the law distinguishes cannabinoids the plant cannot produce from naturally producible cannabinoids made outside it.
These are enacted changes with a revised timetable. A proposal to repeal or extend them again is not itself a change in the law. Sellers should check the operative statute and current agency guidance before placing orders that will remain in inventory across either deadline.
CBD Foods, Supplements, Cosmetics, and Medicines
The FDA’s cannabis guidance says CBD cannot lawfully be marketed as a dietary supplement and generally prohibits introducing foods with added CBD into interstate commerce. The agency retains authority over hemp products even when they are outside the Controlled Substances Act.
CBD in a cosmetic is a different category, but the product still must meet safety and labeling requirements. Claims to treat disease can make a product an unapproved drug. A cream labeled “hemp” is therefore not automatically authorized to claim it treats arthritis or another condition.
Prescription cannabidiol medicine is also distinct from retail CBD. Epidiolex is FDA approved for specific seizure disorders; its approval does not extend to other brands, gummies, or oils. Hemp seed oil is another separate ingredient and should not be confused with a cannabinoid extract.
In its January 2023 decision, the FDA declined petitions to allow CBD in supplements and called for a new regulatory pathway. It identified unresolved safety issues, including liver injury and medication interactions. Widespread retail availability does not resolve those legal or safety questions.
Marijuana-Derived CBD and the 2026 Medical Rule
CBD’s molecular identity does not make all sources and formulations legally interchangeable. Products outside the hemp exemption require a separate analysis under federal controlled-substance rules, medicine rules, and the relevant state program.
A federal final rule effective April 28, 2026 places covered FDA-approved marijuana drug products and marijuana subject to state medical marijuana licensing in Schedule III. It also establishes an expedited DEA registration process for qualifying medical businesses. Other marijuana remains in Schedule I.
Schedule III status is not unrestricted retail legalization. Registration, dispensing, and other federal requirements still matter, as do state patient and business rules. An adult-use dispensary product does not become a federally approved medicine because its label mentions CBD. Conversely, prescription CBD should not be described as available only in states with recreational cannabis laws.
Why State CBD Rules Still Matter
Check the rules for the exact product and activity, rather than relying on a map labeled “CBD legal.” States may distinguish non-intoxicating extracts, edible cannabinoids, inhalable products, and medical cannabis. Requirements can include product registration, seller licensing, testing, age limits, packaging, or stricter THC limits.
For a purchase, consult the state’s health, agriculture, or cannabis regulator. For a business, also check manufacturing and distribution requirements. A permission to grow hemp is not necessarily permission to make CBD food, and a seller’s ability to ship an order does not establish that the destination allows it.
State permission does not cancel FDA restrictions on interstate food commerce. Likewise, a federal extension of the new hemp definition does not automatically postpone a state’s independently enacted restrictions.
Reading CBD Labels and Laboratory Reports
Full-spectrum, broad-spectrum, and isolate describe intended formulations, not legal certifications. Full-spectrum products generally retain multiple cannabinoids, including some THC; broad-spectrum products are marketed as having THC removed; isolate products are marketed as purified CBD. Those labels alone do not prove the contents of a particular batch.
Match the product’s batch number to a recent certificate of analysis. Check which cannabinoids were measured, the reporting limits, THC quantities for the entire container, and relevant contaminant testing. A “not detected” result means below that test’s reporting threshold, not proof of absolute zero. Laboratory results help assess a product but do not replace legal compliance.
For background on the compound and product terminology, see our guide to cannabidiol. Avoid treating a company’s therapeutic claims as proof that a retail product has been approved as a medicine.
Traveling With CBD
Before a trip, check the laws at departure, any transit points, and the destination, along with the carrier’s requirements. The TSA’s cannabis screening page is the relevant starting point for U.S. airport screening, but airport screening policy does not authorize possession under every applicable law.
Original packaging and a batch report can help identify a product; neither creates a legal exemption. Check liquid restrictions separately. For international travel, confirm the destination’s official customs and medicine-import rules before carrying CBD, including whether prior permission or prescription documentation is required. Do not assume a product sold legally at home may cross a border.
What to Check Before Buying or Selling
Start with three questions: does the exact formulation qualify as hemp or have another lawful route; is its intended use and marketing permitted under FDA rules; and does the relevant state permit that product and activity? Then account for the November 12 and December 11 federal changes when assessing future sales.
A low THC percentage, a “CBD legal” label, or availability on a national website answers only part of that analysis. Product-specific rules and the effective dates of enacted changes are more useful than a blanket claim that all hemp CBD is legal nationwide.
